0001285393-25-000002.txt : 20250730
0001285393-25-000002.hdr.sgml : 20250730
20250730075657
ACCESSION NUMBER: 0001285393-25-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06c
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20250730
DATE AS OF CHANGE: 20250730
EFFECTIVENESS DATE: 20250730
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: D. E. Shaw Oculus Fund, L.L.C.
CENTRAL INDEX KEY: 0001285393
ORGANIZATION NAME:
EIN: 200805158
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-64162
FILM NUMBER: 251163996
BUSINESS ADDRESS:
STREET 1: TWO MANHATTAN WEST
STREET 2: 375 NINTH AVENUE, 52ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
BUSINESS PHONE: 212-478-0000
MAIL ADDRESS:
STREET 1: TWO MANHATTAN WEST
STREET 2: 375 NINTH AVENUE, 52ND FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10001
FORMER COMPANY:
FORMER CONFORMED NAME: D E SHAW OCULUS FUND LLC
DATE OF NAME CHANGE: 20040330
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001285393
D. E. Shaw Oculus Fund, L.L.C.
TWO MANHATTAN WEST
375 NINTH AVENUE, 52ND FLOOR
NEW YORK
NY
NEW YORK
10001
212-478-0000
DELAWARE
D E SHAW OCULUS FUND LLC
Limited Liability Company
true
n/a
n/a
D. E. Shaw & Co., L.L.C.
TWO MANHATTAN WEST
375 NINTH AVENUE, 52ND FLOOR
New York
NY
NEW YORK
10001
Director
D. E. Shaw & Co., L.L.C. is the managing member of the issuer.
Pooled Investment Fund
Hedge Fund
false
Decline to Disclose
- 06c
- 3C
- 3C.7
true
0001285393-24-000003
2004-07-01
true
true
false
1000000
D. E. Shaw Securities, L.L.C.
24332
None
None
TWO MANHATTAN WEST
375 NINTH AVENUE, 52ND FLOOR
New York
NY
NEW YORK
10001
All States
true
Indefinite
5488068497
Indefinite
false
589
0
0
D. E. Shaw Securities, L.L.C. received an upfront placement agent fee of $2,500.00 in connection with this offering. This fee was paid by the issuer's investment adviser and did not reduce Total Amount Sold.
0
false
D. E. Shaw Oculus Fund, L.L.C.
/s/ Daniel R. Marcus
Daniel R. Marcus
Authorized Signatory
2025-07-30